microRNA information: hsa-miR-22-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-22-5p | miRbase |
| Accession: | MIMAT0004495 | miRbase |
| Precursor name: | hsa-mir-22 | miRbase |
| Precursor accession: | MI0000078 | miRbase |
| Symbol: | MIR22 | HGNC |
| RefSeq ID: | NR_029494 | GenBank |
| Sequence: | AGUUCUUCAGUGGCAAGCUUUA |
Reported expression in cancers: hsa-miR-22-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-22-5p | breast cancer | upregulation | "miR-22 is up-regulated in numerous metastatic canc ......" | 26512777 | |
| hsa-miR-22-5p | breast cancer | upregulation | "Aberrant Expression of Breast Development Related ......" | 27382390 | qPCR |
| hsa-miR-22-5p | colorectal cancer | downregulation | "Clinical significance of miR 22 expression in pati ......" | 22492279 | qPCR |
| hsa-miR-22-5p | gastric cancer | downregulation | "Reduced expression of miR 22 in gastric cancer is ......" | 23786758 | qPCR |
| hsa-miR-22-5p | gastric cancer | downregulation | "microRNA miR-22 has been reported to be downregula ......" | 25323629 | in situ hybridization |
| hsa-miR-22-5p | gastric cancer | downregulation | "MiR-22 was previously reported to act as tumor sup ......" | 26610210 | |
| hsa-miR-22-5p | kidney renal cell cancer | downregulation | "Accumulating evidence demonstrates that microRNA-2 ......" | 26499759 | qPCR |
| hsa-miR-22-5p | kidney renal cell cancer | downregulation | "MicroRNA miR-22 has previously been reported to be ......" | 27082730 | |
| hsa-miR-22-5p | liver cancer | downregulation | "microRNA 22 downregulated in hepatocellular carcin ......" | 20842113 | qPCR |
| hsa-miR-22-5p | liver cancer | downregulation | "MicroRNA 22 is down regulated in hepatitis B virus ......" | 23582783 | |
| hsa-miR-22-5p | lung cancer | upregulation | "Expression level of miR-22 in lung cancer specimen ......" | 22484852 | qPCR |
| hsa-miR-22-5p | lung squamous cell cancer | upregulation | "Circulating miR 22 miR 24 and miR 34a as novel pre ......" | 23794259 | |
| hsa-miR-22-5p | lymphoma | deregulation | "In addition we derived an 11-miRNA signature 4 upr ......" | 23801630 | |
| hsa-miR-22-5p | melanoma | deregulation | "Comparative microarray analysis of microRNA expres ......" | 23111773 | Microarray; RNA-Seq; qPCR |
| hsa-miR-22-5p | ovarian cancer | downregulation | "Down regulated miR 22 as predictive biomarkers for ......" | 25257702 | qPCR |
| hsa-miR-22-5p | retinoblastoma | upregulation | "Transfection of miR-22 was performed using Lipofec ......" | 22510010 |
Reported cancer pathway affected by hsa-miR-22-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-22-5p | breast cancer | Epithelial mesenchymal transition pathway | "Here we find miR-22 triggers epithelial-mesenchyma ......" | 23830207 | |
| hsa-miR-22-5p | colon cancer | Apoptosis pathway | "Overexpression of miR 22 reverses paclitaxel induc ......" | 21594648 | |
| hsa-miR-22-5p | colorectal cancer | Apoptosis pathway | "MiR 22 regulates 5 FU sensitivity by inhibiting au ......" | 25449431 | |
| hsa-miR-22-5p | endometrial cancer | cell cycle pathway | "miR 22 inhibits proliferation and invasion in estr ......" | 24715036 | |
| hsa-miR-22-5p | gastric cancer | Apoptosis pathway | "Diallyl disulfide suppresses proliferation and ind ......" | 23851184 | |
| hsa-miR-22-5p | gastric cancer | Apoptosis pathway | "EDD1 predicts prognosis and regulates gastric canc ......" | 27124677 | Colony formation |
| hsa-miR-22-5p | kidney renal cell cancer | Apoptosis pathway; Epithelial mesenchymal transition pathway | "MicroRNA 22 functions as a tumor suppressor by tar ......" | 26499759 | Luciferase |
| hsa-miR-22-5p | liver cancer | Apoptosis pathway | "microRNA 22 downregulation of galectin 9 influence ......" | 26239725 | Western blot; Luciferase |
| hsa-miR-22-5p | ovarian cancer | Apoptosis pathway | "We performed deep sequencing to comprehensively pr ......" | 20081105 | |
| hsa-miR-22-5p | ovarian cancer | Apoptosis pathway | "An inhibitory effect of miR 22 on cell migration a ......" | 20869762 | |
| hsa-miR-22-5p | sarcoma | Apoptosis pathway | "miR 22 inhibits tumor growth and metastasis by tar ......" | 27317765 | |
| hsa-miR-22-5p | sarcoma | Apoptosis pathway | "Deep Sequencing Reveals a Novel miR 22 Regulatory ......" | 27569217 |
Reported cancer prognosis affected by hsa-miR-22-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-22-5p | breast cancer | metastasis | "Control of EVI 1 oncogene expression in metastatic ......" | 21057539 | |
| hsa-miR-22-5p | breast cancer | metastasis | "Here we find miR-22 triggers epithelial-mesenchyma ......" | 23830207 | |
| hsa-miR-22-5p | breast cancer | metastasis; staging | "A regulatory loop involving miR 22 Sp1 and c Myc m ......" | 24906624 | |
| hsa-miR-22-5p | breast cancer | staging; metastasis; poor survival | "miR 22 as a prognostic factor targets glucose tran ......" | 25304371 | |
| hsa-miR-22-5p | breast cancer | progression; differentiation | "Systematic integration of molecular profiles ident ......" | 26477310 | |
| hsa-miR-22-5p | breast cancer | progression; metastasis; poor survival | "TIP60 miR 22 axis as a prognostic marker of breast ......" | 26512777 | |
| hsa-miR-22-5p | breast cancer | poor survival | "In this multicenter study a 10-miRNA classifier in ......" | 27566954 | |
| hsa-miR-22-5p | colon cancer | drug resistance; poor survival | "Overexpression of miR 22 reverses paclitaxel induc ......" | 21594648 | |
| hsa-miR-22-5p | colon cancer | cell migration | "MicroRNA 22 is induced by vitamin D and contribute ......" | 22328083 | |
| hsa-miR-22-5p | colorectal cancer | tumorigenesis; poor survival; metastasis | "Clinical significance of miR 22 expression in pati ......" | 22492279 | |
| hsa-miR-22-5p | endometrial cancer | progression | "miR 22 inhibits proliferation and invasion in estr ......" | 24715036 | |
| hsa-miR-22-5p | esophageal cancer | cell migration | "miR 22 is down regulated in esophageal squamous ce ......" | 25516722 | Wound Healing Assay |
| hsa-miR-22-5p | gastric cancer | cell migration; malignant trasformation | "miR 22 is down regulated in gastric cancer and its ......" | 23529765 | Luciferase |
| hsa-miR-22-5p | gastric cancer | worse prognosis; tumorigenesis; staging; metastasis; poor survival; malignant trasformation | "Reduced expression of miR 22 in gastric cancer is ......" | 23786758 | |
| hsa-miR-22-5p | gastric cancer | motility | "MiR 22 suppresses the proliferation and invasion o ......" | 24495805 | Colony formation |
| hsa-miR-22-5p | gastric cancer | metastasis; staging | "microRNA 22 acts as a metastasis suppressor by tar ......" | 25323629 | Luciferase |
| hsa-miR-22-5p | gastric cancer | metastasis; poor survival; cell migration | "MicroRNA 22 inhibits tumor growth and metastasis i ......" | 26610210 | |
| hsa-miR-22-5p | gastric cancer | worse prognosis | "EDD1 predicts prognosis and regulates gastric canc ......" | 27124677 | Colony formation |
| hsa-miR-22-5p | kidney renal cell cancer | staging | "This study aims to profile dysregulated microRNA m ......" | 25938468 | |
| hsa-miR-22-5p | kidney renal cell cancer | tumorigenesis; staging; metastasis | "MicroRNA 22 functions as a tumor suppressor by tar ......" | 26499759 | Luciferase |
| hsa-miR-22-5p | kidney renal cell cancer | cell migration | "MicroRNA 22 is downregulated in clear cell renal c ......" | 27082730 | Western blot; Luciferase |
| hsa-miR-22-5p | liver cancer | worse prognosis; poor survival; progression; tumorigenesis | "microRNA 22 downregulated in hepatocellular carcin ......" | 20842113 | |
| hsa-miR-22-5p | liver cancer | metastasis; differentiation; poor survival; worse prognosis | "MicroRNA 22 expression in hepatocellular carcinoma ......" | 23766411 | |
| hsa-miR-22-5p | lung cancer | progression | "Tumor suppressor miR 22 suppresses lung cancer cel ......" | 22484852 | |
| hsa-miR-22-5p | lung cancer | malignant trasformation | "Diagnostic Value of Circulating Extracellular miR ......" | 24851110 | |
| hsa-miR-22-5p | lung squamous cell cancer | staging; progression; drug resistance | "Circulating miR 22 miR 24 and miR 34a as novel pre ......" | 23794259 | |
| hsa-miR-22-5p | lung squamous cell cancer | progression | "We found that miR-34b and miR-520h might play impo ......" | 25702651 | |
| hsa-miR-22-5p | lymphoma | cell migration; metastasis | "In this study the precise role of miRNA-22 miR-22 ......" | 23440286 | Western blot |
| hsa-miR-22-5p | lymphoma | malignant trasformation | "Jak3 STAT3 and STAT5 inhibit expression of miR 22 ......" | 26244872 | |
| hsa-miR-22-5p | melanoma | metastasis; malignant trasformation | "Comparative microarray analysis of microRNA expres ......" | 23111773 | |
| hsa-miR-22-5p | ovarian cancer | cell migration; metastasis | "An inhibitory effect of miR 22 on cell migration a ......" | 20869762 | |
| hsa-miR-22-5p | ovarian cancer | metastasis | "miRNA microarray was applied to compare the miRNA ......" | 21122376 | |
| hsa-miR-22-5p | ovarian cancer | metastasis | "the differential expression of ezrin in two paired ......" | 21176563 | Western blot |
| hsa-miR-22-5p | ovarian cancer | poor survival; recurrence | "Three miRNAs hsa-miR-16 hsa-miR-22* and ebv-miR-BH ......" | 23554906 | |
| hsa-miR-22-5p | ovarian cancer | worse prognosis; tumorigenesis; staging; metastasis; progression; poor survival | "Down regulated miR 22 as predictive biomarkers for ......" | 25257702 | |
| hsa-miR-22-5p | ovarian cancer | progression; cell migration | "Gene expression profiling analysis of the role of ......" | 27565323 | |
| hsa-miR-22-5p | pancreatic cancer | staging | "Blood-based circulating microRNAs were profiled by ......" | 24578785 | |
| hsa-miR-22-5p | prostate cancer | tumorigenesis; progression | "Previous network analysis and miR arrays suggested ......" | 26544868 | Luciferase |
| hsa-miR-22-5p | sarcoma | drug resistance | "miR 22 targets the 3' UTR of HMGB1 and inhibits th ......" | 24609901 | |
| hsa-miR-22-5p | sarcoma | worse prognosis; poor survival; metastasis; recurrence; drug resistance | "Downregulation of miR 22 acts as an unfavorable pr ......" | 25953260 | |
| hsa-miR-22-5p | sarcoma | metastasis | "miR 22 inhibits tumor growth and metastasis by tar ......" | 27317765 | |
| hsa-miR-22-5p | sarcoma | differentiation; drug resistance | "Deep Sequencing Reveals a Novel miR 22 Regulatory ......" | 27569217 |
Reported gene related to hsa-miR-22-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-22-5p | breast cancer | ERBB3 | "These metastatic cells expressed higher levels of ......" | 21057539 |
| hsa-miR-22-5p | lung cancer | ERBB3 | "Tumor suppressor miR 22 suppresses lung cancer cel ......" | 22484852 |
| hsa-miR-22-5p | retinoblastoma | ERBB3 | "Transfected miR-22 Y79 cells inhibited the cell pr ......" | 22510010 |
| hsa-miR-22-5p | sarcoma | ERBB3 | "Finally we demonstrated the ability of miR-22 to i ......" | 27569217 |
| hsa-miR-22-5p | colon cancer | PTEN | "Overexpression of miR 22 reverses paclitaxel induc ......" | 21594648 |
| hsa-miR-22-5p | kidney renal cell cancer | PTEN | "MicroRNA 22 is downregulated in clear cell renal c ......" | 27082730 |
| hsa-miR-22-5p | prostate cancer | PTEN | "Relevant luciferase+3'-UTR expression studies conf ......" | 26544868 |
| hsa-miR-22-5p | breast cancer | ACLY | "Within this cluster the cancer-associated and card ......" | 26477310 |
| hsa-miR-22-5p | sarcoma | ACLY | "Herein four different types of tumor cells includi ......" | 27317765 |
| hsa-miR-22-5p | breast cancer | ATP8A2 | "Within this cluster the cancer-associated and card ......" | 26477310 |
| hsa-miR-22-5p | sarcoma | ATP8A2 | "miR 22 inhibits tumor growth and metastasis by tar ......" | 27317765 |
| hsa-miR-22-5p | ovarian cancer | CDC37 | "Furthermore overexpression of the putative tumor s ......" | 20081105 |
| hsa-miR-22-5p | retinoblastoma | CDC37 | "Transfected miR-22 Y79 cells inhibited the cell pr ......" | 22510010 |
| hsa-miR-22-5p | breast cancer | ESR1 | "An estrogen receptor alpha suppressor microRNA 22 ......" | 20180843 |
| hsa-miR-22-5p | endometrial cancer | ESR1 | "miR 22 inhibits proliferation and invasion in estr ......" | 24715036 |
| hsa-miR-22-5p | liver cancer | EZR | "MicroRNA 22 expression in hepatocellular carcinoma ......" | 23766411 |
| hsa-miR-22-5p | ovarian cancer | EZR | "2 By a functional screen using miRNA microarray co ......" | 21176563 |
| hsa-miR-22-5p | sarcoma | HMGB1 | "However possibly as a compensatory effect miR-22 w ......" | 24609901 |
| hsa-miR-22-5p | sarcoma | HMGB1 | "In this study we determined the targeting role of ......" | 24752578 |
| hsa-miR-22-5p | breast cancer | SP1 | "We also determined that miR-22 could indirectly pa ......" | 24906624 |
| hsa-miR-22-5p | gastric cancer | SP1 | "miR 22 is down regulated in gastric cancer and its ......" | 23529765 |
| hsa-miR-22-5p | liver cancer | AFP | "However using miRNA panel of miR-22 and miR-199a-3 ......" | 27271989 |
| hsa-miR-22-5p | prostate cancer | AR | "A direct AR regulation of miR-22 miR-29a and miR-1 ......" | 26052614 |
| hsa-miR-22-5p | breast cancer | BSG | "We discovered that miR-22 repressed CD147 expressi ......" | 24906624 |
| hsa-miR-22-5p | colorectal cancer | BTG1 | "B-cell translocation gene 1 BTG1 was identified as ......" | 25449431 |
| hsa-miR-22-5p | colorectal cancer | BTG3 | "B-cell translocation gene 1 BTG1 was identified as ......" | 25449431 |
| hsa-miR-22-5p | liver cancer | CCNA2 | "The sequence of miR-22 which is conserved in mice ......" | 25596928 |
| hsa-miR-22-5p | gastric cancer | CD151 | "MiR 22 suppresses the proliferation and invasion o ......" | 24495805 |
| hsa-miR-22-5p | breast cancer | CDC25C | "These metastatic cells expressed higher levels of ......" | 21057539 |
| hsa-miR-22-5p | liver cancer | CDKN1A | "Overexpression of miR-22 in vitro effectively supp ......" | 23582783 |
| hsa-miR-22-5p | ovarian cancer | DEGS1 | "Nine DEGs as target genes were identified to be re ......" | 27565323 |
| hsa-miR-22-5p | prostate cancer | DUOXA1 | "We previously detected several miRNAs for example ......" | 22815235 |
| hsa-miR-22-5p | prostate cancer | ERBB2 | "Relevant luciferase+3'-UTR expression studies conf ......" | 26544868 |
| hsa-miR-22-5p | liver cancer | HDAC4 | "Furthermore histone deacetylase 4 HDAC4 known to h ......" | 20842113 |
| hsa-miR-22-5p | lymphoma | JAK3 | "Jak3 STAT3 and STAT5 inhibit expression of miR 22 ......" | 26244872 |
| hsa-miR-22-5p | breast cancer | KAT5 | "TIP60 miR 22 axis as a prognostic marker of breast ......" | 26512777 |
| hsa-miR-22-5p | prostate cancer | LAMC1 | "The identification of laminin gamma 1 LAMC1 and my ......" | 26052614 |
| hsa-miR-22-5p | liver cancer | LGALS9 | "microRNA 22 downregulation of galectin 9 influence ......" | 26239725 |
| hsa-miR-22-5p | prostate cancer | MCL1 | "The identification of laminin gamma 1 LAMC1 and my ......" | 26052614 |
| hsa-miR-22-5p | gastric cancer | MMP14 | "MicroRNA 22 inhibits tumor growth and metastasis i ......" | 26610210 |
| hsa-miR-22-5p | gastric cancer | MTDH | "microRNA 22 acts as a metastasis suppressor by tar ......" | 25323629 |
| hsa-miR-22-5p | sarcoma | MYOD1 | "miR-22 was physiologically induced during normal m ......" | 27569217 |
| hsa-miR-22-5p | liver cancer | NR1H4 | "Among the studied primary and secondary bile acids ......" | 25596928 |
| hsa-miR-22-5p | gastric cancer | NTRK2 | "NTRK2 is an oncogene and associated with microRNA ......" | 27662840 |
| hsa-miR-22-5p | ovarian cancer | NUP214 | "In addition to these specific effects reversing th ......" | 20081105 |
| hsa-miR-22-5p | sarcoma | RAB5B | "Moreover restoring miR-22 expression blocked tumor ......" | 27569217 |
| hsa-miR-22-5p | kidney renal cell cancer | SIRT1 | "MicroRNA 22 functions as a tumor suppressor by tar ......" | 26499759 |
| hsa-miR-22-5p | breast cancer | SLC2A1 | "In this study we found that GLUT1 is a direct targ ......" | 25304371 |
| hsa-miR-22-5p | gastric cancer | SNAI1 | "MicroRNA 22 inhibits tumor growth and metastasis i ......" | 26610210 |
| hsa-miR-22-5p | lymphoma | STAT3 | "Jak3 STAT3 and STAT5 inhibit expression of miR 22 ......" | 26244872 |
| hsa-miR-22-5p | sarcoma | TACC1 | "Moreover restoring miR-22 expression blocked tumor ......" | 27569217 |
| hsa-miR-22-5p | ovarian cancer | THM | "Furthermore overexpression of the putative tumor s ......" | 20081105 |
| hsa-miR-22-5p | lymphoma | TIAM1 | "Computational in silico analysis predicted that T- ......" | 23440286 |
| hsa-miR-22-5p | colon cancer | TP53 | "Overexpression of miR 22 reverses paclitaxel induc ......" | 21594648 |
| hsa-miR-22-5p | lymphoma | TSPYL2 | "In conclusion we provide the first evidence that d ......" | 26244872 |
| hsa-miR-22-5p | gastric cancer | UBR5 | "EDD1 predicts prognosis and regulates gastric canc ......" | 27124677 |
| hsa-miR-22-5p | colon cancer | VDR | "In 39 out of 50 78% human colon cancer patients mi ......" | 22328083 |
| hsa-miR-22-5p | colon cancer | VEGFA | "Over-expression of miR-22 inhibits HIF-1α express ......" | 21629773 |
| hsa-miR-22-5p | breast cancer | WLS | "Control of EVI 1 oncogene expression in metastatic ......" | 21057539 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-22-5p | BCLAF1 | 16 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.168; TCGA CESC -0.06; TCGA COAD -0.06; TCGA ESCA -0.07; TCGA HNSC -0.138; TCGA KIRC -0.149; TCGA KIRP -0.175; TCGA LGG -0.076; TCGA LUAD -0.117; TCGA LUSC -0.131; TCGA PAAD -0.183; TCGA PRAD -0.222; TCGA SARC -0.066; TCGA THCA -0.118; TCGA STAD -0.108; TCGA UCEC -0.113 |
hsa-miR-22-5p | FAM117B | 12 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.201; TCGA BRCA -0.075; TCGA HNSC -0.229; TCGA KIRC -0.082; TCGA KIRP -0.143; TCGA LGG -0.241; TCGA LUAD -0.128; TCGA PAAD -0.103; TCGA PRAD -0.201; TCGA SARC -0.231; TCGA THCA -0.193; TCGA UCEC -0.096 |
hsa-miR-22-5p | DNAL1 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.127; TCGA BRCA -0.116; TCGA CESC -0.104; TCGA HNSC -0.065; TCGA KIRC -0.152; TCGA KIRP -0.238; TCGA LUAD -0.124; TCGA LUSC -0.174; TCGA PAAD -0.111; TCGA PRAD -0.076; TCGA STAD -0.18 |
hsa-miR-22-5p | DLG2 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; PAAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.673; TCGA BRCA -0.277; TCGA CESC -0.674; TCGA ESCA -0.482; TCGA HNSC -0.677; TCGA PAAD -0.48; TCGA SARC -0.579; TCGA STAD -0.75; TCGA UCEC -0.275 |
hsa-miR-22-5p | LRCH2 | 9 cancers: BLCA; COAD; LGG; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.178; TCGA COAD -0.24; TCGA LGG -0.244; TCGA LUAD -0.15; TCGA LUSC -0.475; TCGA PAAD -0.359; TCGA SARC -0.399; TCGA STAD -0.425; TCGA UCEC -0.387 |
hsa-miR-22-5p | PER2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.263; TCGA BRCA -0.194; TCGA CESC -0.175; TCGA COAD -0.082; TCGA ESCA -0.332; TCGA HNSC -0.27; TCGA KIRC -0.379; TCGA KIRP -0.16; TCGA LGG -0.054; TCGA PAAD -0.131; TCGA SARC -0.294; TCGA THCA -0.095; TCGA STAD -0.186 |
hsa-miR-22-5p | SNX25 | 11 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.081; TCGA CESC -0.119; TCGA ESCA -0.114; TCGA KIRC -0.169; TCGA KIRP -0.136; TCGA LUAD -0.315; TCGA LUSC -0.278; TCGA PRAD -0.107; TCGA SARC -0.078; TCGA THCA -0.249; TCGA STAD -0.145 |
hsa-miR-22-5p | MAP4K3 | 14 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.158; TCGA CESC -0.1; TCGA COAD -0.103; TCGA HNSC -0.085; TCGA KIRP -0.086; TCGA LGG -0.085; TCGA LUAD -0.107; TCGA LUSC -0.126; TCGA PAAD -0.124; TCGA PRAD -0.244; TCGA SARC -0.144; TCGA THCA -0.09; TCGA STAD -0.162; TCGA UCEC -0.132 |
hsa-miR-22-5p | ZNF180 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.103; TCGA BRCA -0.083; TCGA COAD -0.093; TCGA HNSC -0.081; TCGA KIRC -0.146; TCGA KIRP -0.083; TCGA LUAD -0.088; TCGA LUSC -0.084; TCGA PAAD -0.106; TCGA PRAD -0.162; TCGA STAD -0.103; TCGA UCEC -0.147 |
hsa-miR-22-5p | ZBTB10 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.291; TCGA BRCA -0.099; TCGA CESC -0.231; TCGA COAD -0.341; TCGA HNSC -0.317; TCGA KIRC -0.336; TCGA KIRP -0.33; TCGA LGG -0.223; TCGA LUAD -0.222; TCGA LUSC -0.362; TCGA PRAD -0.301; TCGA SARC -0.335; TCGA THCA -0.269; TCGA STAD -0.307; TCGA UCEC -0.241 |
hsa-miR-22-5p | KIAA0430 | 16 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.242; TCGA BRCA -0.096; TCGA CESC -0.13; TCGA ESCA -0.169; TCGA HNSC -0.143; TCGA KIRC -0.142; TCGA KIRP -0.077; TCGA LGG -0.073; TCGA LUAD -0.097; TCGA LUSC -0.156; TCGA PAAD -0.143; TCGA PRAD -0.156; TCGA SARC -0.17; TCGA THCA -0.164; TCGA STAD -0.203; TCGA UCEC -0.129 |
hsa-miR-22-5p | ZBTB20 | 13 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.305; TCGA BRCA -0.12; TCGA ESCA -0.464; TCGA HNSC -0.401; TCGA KIRC -0.299; TCGA KIRP -0.298; TCGA LGG -0.354; TCGA LUSC -0.367; TCGA PAAD -0.231; TCGA PRAD -0.282; TCGA SARC -0.307; TCGA THCA -0.21; TCGA STAD -0.205 |
hsa-miR-22-5p | WDR47 | 11 cancers: BLCA; COAD; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.128; TCGA COAD -0.102; TCGA KIRC -0.187; TCGA KIRP -0.149; TCGA LUAD -0.188; TCGA PAAD -0.155; TCGA PRAD -0.118; TCGA SARC -0.155; TCGA THCA -0.081; TCGA STAD -0.229; TCGA UCEC -0.126 |
hsa-miR-22-5p | AFF1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.164; TCGA BRCA -0.099; TCGA CESC -0.131; TCGA COAD -0.106; TCGA ESCA -0.22; TCGA HNSC -0.162; TCGA KIRC -0.189; TCGA KIRP -0.073; TCGA LUAD -0.142; TCGA LUSC -0.22; TCGA PAAD -0.181; TCGA PRAD -0.192; TCGA SARC -0.213; TCGA THCA -0.066; TCGA STAD -0.191 |
hsa-miR-22-5p | ZNF829 | 13 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.197; TCGA BRCA -0.128; TCGA HNSC -0.465; TCGA KIRC -0.36; TCGA KIRP -0.275; TCGA LUAD -0.146; TCGA LUSC -0.316; TCGA PAAD -0.299; TCGA PRAD -0.362; TCGA SARC -0.241; TCGA THCA -0.3; TCGA STAD -0.385; TCGA UCEC -0.144 |
hsa-miR-22-5p | ABCD3 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.101; TCGA BRCA -0.167; TCGA CESC -0.093; TCGA ESCA -0.158; TCGA HNSC -0.181; TCGA LUAD -0.163; TCGA PAAD -0.117; TCGA PRAD -0.131; TCGA THCA -0.187 |
hsa-miR-22-5p | ARID5B | 9 cancers: BLCA; HNSC; KIRC; LUAD; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.251; TCGA HNSC -0.218; TCGA KIRC -0.171; TCGA LUAD -0.105; TCGA PAAD -0.153; TCGA PRAD -0.2; TCGA SARC -0.225; TCGA STAD -0.171; TCGA UCEC -0.156 |
hsa-miR-22-5p | TAF9B | 17 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.195; TCGA BRCA -0.06; TCGA CESC -0.093; TCGA COAD -0.117; TCGA HNSC -0.086; TCGA KIRC -0.117; TCGA KIRP -0.158; TCGA LGG -0.134; TCGA LIHC -0.11; TCGA LUAD -0.202; TCGA LUSC -0.121; TCGA PAAD -0.173; TCGA PRAD -0.117; TCGA SARC -0.249; TCGA THCA -0.075; TCGA STAD -0.254; TCGA UCEC -0.182 |
hsa-miR-22-5p | USP46 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.134; TCGA BRCA -0.077; TCGA CESC -0.123; TCGA COAD -0.089; TCGA HNSC -0.152; TCGA LUAD -0.072; TCGA PAAD -0.159; TCGA PRAD -0.159; TCGA STAD -0.129; TCGA UCEC -0.112 |
hsa-miR-22-5p | SMC5 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.073; TCGA COAD -0.134; TCGA ESCA -0.174; TCGA HNSC -0.137; TCGA KIRC -0.213; TCGA KIRP -0.247; TCGA LUAD -0.117; TCGA LUSC -0.173; TCGA PRAD -0.161; TCGA THCA -0.214; TCGA STAD -0.13; TCGA UCEC -0.134 |
hsa-miR-22-5p | COL4A3BP | 10 cancers: BLCA; BRCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.182; TCGA BRCA -0.057; TCGA HNSC -0.132; TCGA KIRC -0.092; TCGA LUAD -0.203; TCGA LUSC -0.168; TCGA PAAD -0.19; TCGA PRAD -0.178; TCGA SARC -0.133; TCGA STAD -0.145 |
hsa-miR-22-5p | ANKHD1 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.117; TCGA BRCA -0.074; TCGA CESC -0.087; TCGA COAD -0.106; TCGA HNSC -0.173; TCGA KIRC -0.121; TCGA KIRP -0.109; TCGA LGG -0.147; TCGA LIHC -0.113; TCGA LUAD -0.16; TCGA LUSC -0.159; TCGA PAAD -0.123; TCGA PRAD -0.152; TCGA SARC -0.179; TCGA THCA -0.107 |
hsa-miR-22-5p | EDA2R | 9 cancers: BLCA; BRCA; COAD; KIRC; LUAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.262; TCGA BRCA -0.122; TCGA COAD -0.385; TCGA KIRC -0.278; TCGA LUAD -0.208; TCGA SARC -0.356; TCGA THCA -0.173; TCGA STAD -0.29; TCGA UCEC -0.226 |
hsa-miR-22-5p | CC2D2A | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.294; TCGA BRCA -0.084; TCGA CESC -0.248; TCGA COAD -0.205; TCGA ESCA -0.267; TCGA HNSC -0.19; TCGA KIRC -0.131; TCGA KIRP -0.075; TCGA LGG -0.137; TCGA LUAD -0.161; TCGA LUSC -0.241; TCGA PAAD -0.204; TCGA PRAD -0.143; TCGA SARC -0.365; TCGA STAD -0.387; TCGA UCEC -0.118 |
hsa-miR-22-5p | SYNRG | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.136; TCGA BRCA -0.097; TCGA CESC -0.081; TCGA COAD -0.077; TCGA ESCA -0.129; TCGA HNSC -0.211; TCGA KIRP -0.054; TCGA LGG -0.139; TCGA LIHC -0.058; TCGA LUAD -0.106; TCGA LUSC -0.21; TCGA PRAD -0.173; TCGA THCA -0.122; TCGA STAD -0.074 |
hsa-miR-22-5p | KANK2 | 11 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LUAD; LUSC; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.263; TCGA CESC -0.206; TCGA ESCA -0.329; TCGA KIRC -0.163; TCGA KIRP -0.092; TCGA LUAD -0.131; TCGA LUSC -0.306; TCGA SARC -0.504; TCGA THCA -0.335; TCGA STAD -0.427; TCGA UCEC -0.302 |
hsa-miR-22-5p | PIP5K1B | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; UCEC | MirTarget | TCGA BLCA -0.531; TCGA BRCA -0.147; TCGA CESC -0.608; TCGA ESCA -0.844; TCGA HNSC -0.398; TCGA LUAD -0.277; TCGA LUSC -0.601; TCGA PAAD -0.352; TCGA SARC -0.441; TCGA UCEC -0.17 |
hsa-miR-22-5p | ZDHHC15 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.548; TCGA BRCA -0.143; TCGA CESC -0.682; TCGA ESCA -0.483; TCGA HNSC -0.568; TCGA KIRC -0.494; TCGA LGG -0.08; TCGA LUAD -0.346; TCGA LUSC -0.504; TCGA PAAD -0.313; TCGA SARC -0.774; TCGA THCA -0.058; TCGA STAD -0.51; TCGA UCEC -0.424 |
hsa-miR-22-5p | ARRDC3 | 9 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.086; TCGA HNSC -0.291; TCGA KIRC -0.157; TCGA KIRP -0.131; TCGA LGG -0.082; TCGA LUAD -0.248; TCGA PRAD -0.269; TCGA THCA -0.205; TCGA STAD -0.267 |
hsa-miR-22-5p | TRUB1 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.117; TCGA BRCA -0.065; TCGA COAD -0.156; TCGA HNSC -0.077; TCGA KIRP -0.103; TCGA LGG -0.089; TCGA LUAD -0.138; TCGA PAAD -0.126; TCGA PRAD -0.261; TCGA SARC -0.068; TCGA THCA -0.067; TCGA UCEC -0.139 |
hsa-miR-22-5p | INTS2 | 15 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.07; TCGA BRCA -0.068; TCGA COAD -0.103; TCGA HNSC -0.184; TCGA KIRC -0.117; TCGA KIRP -0.19; TCGA LGG -0.158; TCGA LIHC -0.117; TCGA LUAD -0.097; TCGA LUSC -0.149; TCGA PAAD -0.155; TCGA PRAD -0.252; TCGA SARC -0.176; TCGA STAD -0.092; TCGA UCEC -0.114 |
hsa-miR-22-5p | GTF2A1 | 13 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.252; TCGA COAD -0.265; TCGA ESCA -0.127; TCGA HNSC -0.418; TCGA KIRC -0.4; TCGA KIRP -0.419; TCGA LUAD -0.302; TCGA LUSC -0.295; TCGA PAAD -0.28; TCGA PRAD -0.455; TCGA SARC -0.151; TCGA THCA -0.422; TCGA STAD -0.112 |
hsa-miR-22-5p | GFRA1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.845; TCGA BRCA -0.692; TCGA CESC -0.411; TCGA COAD -0.39; TCGA ESCA -0.733; TCGA HNSC -0.581; TCGA LGG -0.658; TCGA LUAD -0.48; TCGA LUSC -0.67; TCGA PAAD -0.405; TCGA STAD -0.703; TCGA UCEC -0.67 |
hsa-miR-22-5p | UNC13B | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; STAD | MirTarget | TCGA BLCA -0.114; TCGA BRCA -0.058; TCGA CESC -0.123; TCGA ESCA -0.306; TCGA HNSC -0.222; TCGA LUAD -0.256; TCGA LUSC -0.296; TCGA PAAD -0.163; TCGA SARC -0.178; TCGA STAD -0.09 |
hsa-miR-22-5p | NUDT21 | 13 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.072; TCGA COAD -0.082; TCGA HNSC -0.059; TCGA KIRC -0.137; TCGA KIRP -0.109; TCGA LGG -0.111; TCGA LUAD -0.105; TCGA PAAD -0.11; TCGA PRAD -0.183; TCGA SARC -0.056; TCGA THCA -0.165; TCGA STAD -0.071; TCGA UCEC -0.16 |
hsa-miR-22-5p | LPIN2 | 9 cancers: BLCA; CESC; HNSC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.156; TCGA CESC -0.178; TCGA HNSC -0.186; TCGA LUAD -0.101; TCGA LUSC -0.318; TCGA PRAD -0.183; TCGA SARC -0.104; TCGA THCA -0.24; TCGA UCEC -0.1 |
hsa-miR-22-5p | SMG1 | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.138; TCGA BRCA -0.052; TCGA COAD -0.092; TCGA HNSC -0.076; TCGA KIRC -0.149; TCGA KIRP -0.168; TCGA LGG -0.075; TCGA LUSC -0.125; TCGA PRAD -0.228; TCGA SARC -0.158; TCGA THCA -0.096; TCGA STAD -0.14; TCGA UCEC -0.064 |
hsa-miR-22-5p | MAGI2 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.431; TCGA BRCA -0.138; TCGA CESC -0.242; TCGA HNSC -0.167; TCGA KIRP -0.153; TCGA LUAD -0.105; TCGA LUSC -0.221; TCGA PAAD -0.293; TCGA SARC -0.354; TCGA STAD -0.452; TCGA UCEC -0.32 |
hsa-miR-22-5p | CD302 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; UCEC | MirTarget | TCGA BLCA -0.132; TCGA BRCA -0.073; TCGA CESC -0.173; TCGA COAD -0.106; TCGA ESCA -0.331; TCGA HNSC -0.255; TCGA LUAD -0.365; TCGA LUSC -0.365; TCGA PAAD -0.32; TCGA PRAD -0.268; TCGA UCEC -0.112 |
hsa-miR-22-5p | CACNA2D2 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.36; TCGA BRCA -0.54; TCGA CESC -0.349; TCGA ESCA -0.541; TCGA HNSC -0.36; TCGA KIRP -0.146; TCGA LGG -0.252; TCGA LUAD -0.678; TCGA LUSC -0.674; TCGA PAAD -0.648; TCGA PRAD -0.235; TCGA SARC -0.369; TCGA STAD -0.339; TCGA UCEC -0.435 |
hsa-miR-22-5p | ADAM22 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.496; TCGA BRCA -0.205; TCGA CESC -0.689; TCGA COAD -0.271; TCGA ESCA -0.5; TCGA HNSC -0.498; TCGA KIRC -0.395; TCGA LGG -0.284; TCGA LUAD -0.223; TCGA LUSC -0.655; TCGA PAAD -0.361; TCGA PRAD -0.396; TCGA SARC -1.122; TCGA STAD -0.268; TCGA UCEC -0.266 |
hsa-miR-22-5p | PHF20 | 14 cancers: BLCA; BRCA; CESC; COAD; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.086; TCGA BRCA -0.062; TCGA CESC -0.107; TCGA COAD -0.104; TCGA KIRP -0.08; TCGA LGG -0.092; TCGA LIHC -0.075; TCGA LUAD -0.107; TCGA LUSC -0.148; TCGA PRAD -0.116; TCGA SARC -0.075; TCGA THCA -0.126; TCGA STAD -0.075; TCGA UCEC -0.111 |
hsa-miR-22-5p | KIF1B | 11 cancers: BLCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.154; TCGA HNSC -0.077; TCGA KIRC -0.138; TCGA KIRP -0.109; TCGA LUAD -0.085; TCGA LUSC -0.176; TCGA PAAD -0.156; TCGA PRAD -0.14; TCGA THCA -0.185; TCGA STAD -0.193; TCGA UCEC -0.12 |
hsa-miR-22-5p | HIPK2 | 11 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP; miRNATAP | TCGA BLCA -0.105; TCGA BRCA -0.093; TCGA HNSC -0.309; TCGA KIRC -0.233; TCGA KIRP -0.224; TCGA LGG -0.12; TCGA LUAD -0.096; TCGA LUSC -0.3; TCGA PAAD -0.249; TCGA PRAD -0.284; TCGA THCA -0.286 |
hsa-miR-22-5p | MAP3K13 | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.137; TCGA COAD -0.151; TCGA HNSC -0.281; TCGA KIRC -0.222; TCGA KIRP -0.151; TCGA LUAD -0.172; TCGA PRAD -0.36; TCGA SARC -0.252; TCGA THCA -0.3 |
hsa-miR-22-5p | SORBS1 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.51; TCGA CESC -0.355; TCGA COAD -0.365; TCGA ESCA -0.728; TCGA KIRP -0.172; TCGA LUAD -0.286; TCGA LUSC -0.479; TCGA PAAD -0.279; TCGA SARC -1.238; TCGA STAD -0.825; TCGA UCEC -0.385 |
hsa-miR-22-5p | TNRC6B | 12 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.208; TCGA CESC -0.1; TCGA ESCA -0.139; TCGA HNSC -0.179; TCGA KIRC -0.086; TCGA KIRP -0.175; TCGA LGG -0.149; TCGA PAAD -0.124; TCGA PRAD -0.21; TCGA SARC -0.13; TCGA THCA -0.103; TCGA STAD -0.143 |
hsa-miR-22-5p | RIMS4 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.347; TCGA BRCA -0.352; TCGA ESCA -0.552; TCGA HNSC -0.448; TCGA KIRP -0.316; TCGA LUAD -0.22; TCGA LUSC -0.646; TCGA PAAD -0.317; TCGA STAD -0.515; TCGA UCEC -0.294 |
hsa-miR-22-5p | ZNF516 | 9 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LIHC; LUSC; THCA; STAD | mirMAP | TCGA BLCA -0.17; TCGA BRCA -0.319; TCGA HNSC -0.22; TCGA KIRC -0.199; TCGA LGG -0.196; TCGA LIHC -0.123; TCGA LUSC -0.161; TCGA THCA -0.309; TCGA STAD -0.267 |
hsa-miR-22-5p | TBL1X | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.288; TCGA BRCA -0.114; TCGA CESC -0.138; TCGA HNSC -0.408; TCGA KIRC -0.201; TCGA KIRP -0.072; TCGA LIHC -0.165; TCGA SARC -0.343; TCGA THCA -0.091; TCGA STAD -0.13; TCGA UCEC -0.222 |
hsa-miR-22-5p | MAPK8 | 14 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.124; TCGA BRCA -0.112; TCGA COAD -0.129; TCGA ESCA -0.161; TCGA KIRC -0.27; TCGA KIRP -0.255; TCGA LGG -0.175; TCGA LUAD -0.167; TCGA LUSC -0.153; TCGA PAAD -0.157; TCGA PRAD -0.344; TCGA THCA -0.182; TCGA STAD -0.118; TCGA UCEC -0.12 |
hsa-miR-22-5p | PHF12 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUSC; PRAD; SARC | mirMAP | TCGA BLCA -0.119; TCGA BRCA -0.081; TCGA CESC -0.101; TCGA HNSC -0.083; TCGA KIRP -0.138; TCGA LGG -0.119; TCGA LIHC -0.073; TCGA LUSC -0.088; TCGA PRAD -0.128; TCGA SARC -0.181 |
hsa-miR-22-5p | SEMA5A | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.343; TCGA BRCA -0.197; TCGA COAD -0.238; TCGA ESCA -0.249; TCGA HNSC -0.404; TCGA LGG -0.184; TCGA LUAD -0.199; TCGA LUSC -0.553; TCGA PAAD -0.231; TCGA PRAD -0.225; TCGA SARC -0.416; TCGA THCA -0.185; TCGA UCEC -0.164 |
hsa-miR-22-5p | PRLR | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; PAAD; SARC | mirMAP | TCGA BLCA -0.298; TCGA BRCA -0.385; TCGA CESC -0.673; TCGA COAD -0.211; TCGA ESCA -0.512; TCGA HNSC -0.279; TCGA LIHC -0.371; TCGA PAAD -0.441; TCGA SARC -0.566 |
hsa-miR-22-5p | RAD50 | 16 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.121; TCGA BRCA -0.084; TCGA COAD -0.162; TCGA HNSC -0.088; TCGA KIRC -0.106; TCGA KIRP -0.177; TCGA LGG -0.064; TCGA LIHC -0.112; TCGA LUAD -0.139; TCGA LUSC -0.17; TCGA PAAD -0.152; TCGA PRAD -0.216; TCGA SARC -0.139; TCGA THCA -0.186; TCGA STAD -0.09; TCGA UCEC -0.081 |
hsa-miR-22-5p | PARD3B | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.482; TCGA BRCA -0.172; TCGA CESC -0.365; TCGA COAD -0.318; TCGA ESCA -0.746; TCGA HNSC -0.551; TCGA KIRC -0.313; TCGA KIRP -0.428; TCGA LGG -0.215; TCGA LIHC -0.239; TCGA LUAD -0.372; TCGA LUSC -0.793; TCGA PAAD -0.431; TCGA PRAD -0.382; TCGA SARC -0.406; TCGA THCA -0.566; TCGA STAD -0.286; TCGA UCEC -0.156 |
hsa-miR-22-5p | PANK3 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP | TCGA BLCA -0.124; TCGA BRCA -0.152; TCGA COAD -0.142; TCGA ESCA -0.135; TCGA HNSC -0.155; TCGA KIRC -0.158; TCGA LUAD -0.163; TCGA LUSC -0.115; TCGA PAAD -0.181; TCGA PRAD -0.295; TCGA THCA -0.124 |
hsa-miR-22-5p | PAIP2B | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.279; TCGA BRCA -0.126; TCGA CESC -0.21; TCGA HNSC -0.384; TCGA KIRC -0.306; TCGA LUAD -0.206; TCGA LUSC -0.283; TCGA PRAD -0.139; TCGA SARC -0.316; TCGA STAD -0.281; TCGA UCEC -0.333 |
hsa-miR-22-5p | AHDC1 | 9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.199; TCGA BRCA -0.064; TCGA HNSC -0.19; TCGA KIRC -0.112; TCGA KIRP -0.1; TCGA SARC -0.148; TCGA THCA -0.104; TCGA STAD -0.149; TCGA UCEC -0.137 |
hsa-miR-22-5p | MKLN1 | 15 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.112; TCGA COAD -0.051; TCGA ESCA -0.137; TCGA HNSC -0.118; TCGA KIRC -0.09; TCGA KIRP -0.158; TCGA LGG -0.162; TCGA LUAD -0.089; TCGA LUSC -0.076; TCGA PAAD -0.114; TCGA PRAD -0.102; TCGA SARC -0.084; TCGA THCA -0.073; TCGA STAD -0.125; TCGA UCEC -0.121 |
hsa-miR-22-5p | ZNF557 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.128; TCGA BRCA -0.061; TCGA CESC -0.068; TCGA HNSC -0.069; TCGA KIRC -0.057; TCGA KIRP -0.095; TCGA LGG -0.096; TCGA LUAD -0.092; TCGA PRAD -0.093; TCGA SARC -0.068; TCGA STAD -0.12 |
hsa-miR-22-5p | ACVR1B | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PRAD | mirMAP | TCGA BLCA -0.147; TCGA BRCA -0.118; TCGA CESC -0.094; TCGA COAD -0.127; TCGA ESCA -0.137; TCGA HNSC -0.149; TCGA KIRP -0.072; TCGA LUAD -0.133; TCGA PRAD -0.131 |
hsa-miR-22-5p | NTRK3 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUSC; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.517; TCGA BRCA -0.45; TCGA CESC -0.471; TCGA ESCA -0.751; TCGA HNSC -0.531; TCGA LGG -0.143; TCGA LUSC -0.601; TCGA SARC -0.668; TCGA THCA -0.283; TCGA STAD -0.481; TCGA UCEC -0.42 |
hsa-miR-22-5p | FTO | 12 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.098; TCGA BRCA -0.097; TCGA COAD -0.061; TCGA KIRC -0.132; TCGA KIRP -0.097; TCGA LUAD -0.143; TCGA LUSC -0.097; TCGA PAAD -0.172; TCGA PRAD -0.123; TCGA SARC -0.051; TCGA THCA -0.056; TCGA STAD -0.197 |
hsa-miR-22-5p | ZCCHC14 | 10 cancers: BLCA; KIRC; KIRP; LGG; LUSC; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.127; TCGA KIRC -0.122; TCGA KIRP -0.203; TCGA LGG -0.214; TCGA LUSC -0.071; TCGA PAAD -0.089; TCGA SARC -0.088; TCGA THCA -0.155; TCGA STAD -0.074; TCGA UCEC -0.058 |
hsa-miR-22-5p | RHBDL3 | 12 cancers: BLCA; BRCA; CESC; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.366; TCGA BRCA -0.161; TCGA CESC -0.328; TCGA HNSC -0.326; TCGA LGG -0.354; TCGA LIHC -0.666; TCGA LUAD -0.173; TCGA LUSC -0.337; TCGA PAAD -0.278; TCGA SARC -0.801; TCGA STAD -0.238; TCGA UCEC -0.356 |
hsa-miR-22-5p | LPP | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.324; TCGA COAD -0.187; TCGA ESCA -0.213; TCGA HNSC -0.287; TCGA KIRC -0.17; TCGA KIRP -0.222; TCGA LUAD -0.183; TCGA LUSC -0.148; TCGA PRAD -0.318; TCGA SARC -0.633; TCGA STAD -0.513 |
hsa-miR-22-5p | PIK3R1 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.293; TCGA CESC -0.166; TCGA COAD -0.186; TCGA ESCA -0.272; TCGA HNSC -0.186; TCGA KIRP -0.181; TCGA LGG -0.264; TCGA LUAD -0.249; TCGA LUSC -0.171; TCGA PAAD -0.208; TCGA PRAD -0.183; TCGA SARC -0.273; TCGA THCA -0.216; TCGA STAD -0.283 |
hsa-miR-22-5p | RMND5B | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; SARC; THCA | mirMAP | TCGA BLCA -0.098; TCGA BRCA -0.075; TCGA CESC -0.086; TCGA ESCA -0.132; TCGA HNSC -0.232; TCGA LGG -0.116; TCGA LIHC -0.062; TCGA SARC -0.23; TCGA THCA -0.081 |
hsa-miR-22-5p | MGAT5 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.265; TCGA BRCA -0.154; TCGA COAD -0.269; TCGA ESCA -0.426; TCGA HNSC -0.523; TCGA KIRC -0.357; TCGA KIRP -0.374; TCGA LUAD -0.293; TCGA LUSC -0.452; TCGA PRAD -0.708; TCGA SARC -0.335; TCGA THCA -0.539 |
hsa-miR-22-5p | PRKCA | 11 cancers: BLCA; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.259; TCGA ESCA -0.29; TCGA KIRP -0.183; TCGA LGG -0.11; TCGA LIHC -0.251; TCGA LUAD -0.178; TCGA LUSC -0.157; TCGA PAAD -0.132; TCGA PRAD -0.122; TCGA STAD -0.177; TCGA UCEC -0.152 |
hsa-miR-22-5p | UBN2 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.165; TCGA BRCA -0.084; TCGA COAD -0.062; TCGA ESCA -0.095; TCGA HNSC -0.152; TCGA KIRC -0.137; TCGA KIRP -0.203; TCGA LGG -0.196; TCGA LUSC -0.103; TCGA PRAD -0.137; TCGA SARC -0.092; TCGA STAD -0.132 |
hsa-miR-22-5p | WASF2 | 10 cancers: BLCA; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.184; TCGA HNSC -0.219; TCGA KIRC -0.226; TCGA KIRP -0.121; TCGA LIHC -0.067; TCGA LUAD -0.084; TCGA PRAD -0.171; TCGA THCA -0.192; TCGA STAD -0.1; TCGA UCEC -0.092 |
hsa-miR-22-5p | SHROOM4 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.217; TCGA CESC -0.218; TCGA COAD -0.306; TCGA ESCA -0.242; TCGA HNSC -0.341; TCGA KIRC -0.35; TCGA KIRP -0.185; TCGA LUAD -0.38; TCGA THCA -0.619; TCGA STAD -0.193; TCGA UCEC -0.165 |
hsa-miR-22-5p | ZSCAN12 | 15 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.194; TCGA BRCA -0.1; TCGA COAD -0.17; TCGA KIRC -0.274; TCGA KIRP -0.199; TCGA LGG -0.091; TCGA LIHC -0.125; TCGA LUAD -0.226; TCGA LUSC -0.145; TCGA PAAD -0.158; TCGA PRAD -0.159; TCGA SARC -0.189; TCGA THCA -0.088; TCGA STAD -0.273; TCGA UCEC -0.351 |
hsa-miR-22-5p | PRKAA2 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.641; TCGA BRCA -0.236; TCGA CESC -0.47; TCGA HNSC -0.393; TCGA KIRC -0.273; TCGA KIRP -0.131; TCGA LIHC -0.407; TCGA LUSC -0.337; TCGA PRAD -0.145; TCGA SARC -1.181; TCGA STAD -1.031; TCGA UCEC -0.167 |
hsa-miR-22-5p | PEX19 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.115; TCGA BRCA -0.068; TCGA CESC -0.106; TCGA COAD -0.094; TCGA ESCA -0.098; TCGA HNSC -0.086; TCGA KIRC -0.103; TCGA KIRP -0.076; TCGA LIHC -0.131; TCGA LUAD -0.169; TCGA LUSC -0.15; TCGA PAAD -0.157; TCGA PRAD -0.122; TCGA SARC -0.145; TCGA THCA -0.204; TCGA UCEC -0.179 |
hsa-miR-22-5p | TMEM184C | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.075; TCGA BRCA -0.053; TCGA COAD -0.158; TCGA ESCA -0.103; TCGA HNSC -0.154; TCGA KIRC -0.155; TCGA KIRP -0.128; TCGA LUAD -0.095; TCGA LUSC -0.137; TCGA PAAD -0.186; TCGA PRAD -0.273; TCGA THCA -0.141; TCGA UCEC -0.092 |
hsa-miR-22-5p | KIAA1958 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.183; TCGA BRCA -0.194; TCGA CESC -0.166; TCGA COAD -0.239; TCGA ESCA -0.326; TCGA HNSC -0.457; TCGA KIRC -0.312; TCGA KIRP -0.303; TCGA LGG -0.112; TCGA LUAD -0.315; TCGA LUSC -0.413; TCGA PAAD -0.238; TCGA PRAD -0.336; TCGA SARC -0.518; TCGA THCA -0.351 |
hsa-miR-22-5p | ZNF592 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.089; TCGA BRCA -0.058; TCGA CESC -0.066; TCGA ESCA -0.111; TCGA HNSC -0.103; TCGA KIRC -0.099; TCGA KIRP -0.131; TCGA LGG -0.103; TCGA LUAD -0.055; TCGA LUSC -0.121; TCGA PAAD -0.099; TCGA PRAD -0.091; TCGA SARC -0.07; TCGA THCA -0.19 |
hsa-miR-22-5p | KLF13 | 10 cancers: BLCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.117; TCGA KIRC -0.266; TCGA KIRP -0.181; TCGA LIHC -0.124; TCGA LUAD -0.145; TCGA LUSC -0.127; TCGA PAAD -0.119; TCGA PRAD -0.255; TCGA THCA -0.151; TCGA UCEC -0.159 |
hsa-miR-22-5p | RALGAPB | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.07; TCGA BRCA -0.061; TCGA CESC -0.066; TCGA COAD -0.128; TCGA HNSC -0.057; TCGA KIRP -0.097; TCGA LUAD -0.084; TCGA LUSC -0.117; TCGA PRAD -0.187; TCGA THCA -0.112; TCGA STAD -0.082; TCGA UCEC -0.063 |
hsa-miR-22-5p | LONRF2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.829; TCGA BRCA -0.509; TCGA CESC -0.858; TCGA COAD -0.367; TCGA ESCA -0.806; TCGA HNSC -0.532; TCGA KIRP -0.503; TCGA LUSC -0.391; TCGA PAAD -0.479; TCGA PRAD -0.068; TCGA SARC -1.524; TCGA THCA -0.757; TCGA STAD -0.903; TCGA UCEC -0.389 |
hsa-miR-22-5p | ATF7 | 13 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.172; TCGA COAD -0.124; TCGA ESCA -0.102; TCGA HNSC -0.156; TCGA KIRC -0.175; TCGA KIRP -0.22; TCGA LGG -0.068; TCGA LUAD -0.111; TCGA LUSC -0.155; TCGA PAAD -0.107; TCGA PRAD -0.174; TCGA SARC -0.163; TCGA STAD -0.161 |
hsa-miR-22-5p | KSR2 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC | mirMAP | TCGA BLCA -0.627; TCGA BRCA -0.409; TCGA CESC -0.535; TCGA ESCA -0.447; TCGA HNSC -0.547; TCGA KIRP -0.311; TCGA LGG -0.23; TCGA LUAD -0.27; TCGA LUSC -0.611; TCGA PAAD -0.286; TCGA PRAD -0.272; TCGA SARC -0.304 |
hsa-miR-22-5p | ZMAT3 | 9 cancers: BLCA; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.108; TCGA COAD -0.233; TCGA HNSC -0.39; TCGA LUAD -0.181; TCGA LUSC -0.241; TCGA PAAD -0.208; TCGA PRAD -0.117; TCGA THCA -0.304; TCGA STAD -0.2 |
hsa-miR-22-5p | ZBTB4 | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.157; TCGA BRCA -0.116; TCGA HNSC -0.078; TCGA KIRC -0.166; TCGA KIRP -0.096; TCGA LUAD -0.085; TCGA PAAD -0.08; TCGA THCA -0.103; TCGA STAD -0.246; TCGA UCEC -0.064 |
hsa-miR-22-5p | GNG7 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.376; TCGA BRCA -0.261; TCGA CESC -0.242; TCGA ESCA -0.416; TCGA HNSC -0.378; TCGA KIRC -0.164; TCGA LUAD -0.119; TCGA LUSC -0.216; TCGA SARC -0.388; TCGA STAD -0.395; TCGA UCEC -0.296 |
hsa-miR-22-5p | SAMD12 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; SARC; THCA | mirMAP | TCGA BLCA -0.416; TCGA BRCA -0.181; TCGA CESC -0.341; TCGA COAD -0.157; TCGA ESCA -0.588; TCGA HNSC -0.766; TCGA KIRP -0.195; TCGA LUAD -0.082; TCGA PAAD -0.177; TCGA SARC -0.291; TCGA THCA -0.071 |
hsa-miR-22-5p | UNC5C | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.267; TCGA BRCA -0.153; TCGA COAD -0.329; TCGA HNSC -0.245; TCGA KIRC -0.257; TCGA LUAD -0.218; TCGA LUSC -0.513; TCGA PRAD -0.153; TCGA SARC -0.492; TCGA THCA -0.638 |
hsa-miR-22-5p | BTBD9 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.163; TCGA BRCA -0.122; TCGA CESC -0.168; TCGA ESCA -0.248; TCGA HNSC -0.177; TCGA KIRC -0.089; TCGA LUAD -0.18; TCGA LUSC -0.233; TCGA PAAD -0.117; TCGA PRAD -0.164; TCGA THCA -0.114; TCGA STAD -0.095 |
hsa-miR-22-5p | NR2F2 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.132; TCGA BRCA -0.071; TCGA CESC -0.286; TCGA ESCA -0.343; TCGA HNSC -0.211; TCGA KIRP -0.27; TCGA LUAD -0.092; TCGA LUSC -0.191; TCGA PAAD -0.149; TCGA PRAD -0.07; TCGA SARC -0.475; TCGA STAD -0.146; TCGA UCEC -0.152 |
hsa-miR-22-5p | C3orf70 | 9 cancers: BLCA; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.545; TCGA ESCA -0.305; TCGA HNSC -0.476; TCGA KIRC -0.269; TCGA LUAD -0.143; TCGA LUSC -0.446; TCGA SARC -0.785; TCGA STAD -0.65; TCGA UCEC -0.432 |
hsa-miR-22-5p | TEAD1 | 13 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.182; TCGA COAD -0.095; TCGA ESCA -0.121; TCGA KIRC -0.128; TCGA KIRP -0.15; TCGA LGG -0.235; TCGA LUSC -0.224; TCGA PAAD -0.135; TCGA PRAD -0.107; TCGA SARC -0.212; TCGA THCA -0.253; TCGA STAD -0.386; TCGA UCEC -0.172 |
hsa-miR-22-5p | LDOC1L | 16 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.314; TCGA BRCA -0.112; TCGA CESC -0.209; TCGA ESCA -0.241; TCGA HNSC -0.164; TCGA KIRC -0.204; TCGA KIRP -0.184; TCGA LGG -0.183; TCGA LUAD -0.128; TCGA LUSC -0.236; TCGA PAAD -0.199; TCGA PRAD -0.243; TCGA SARC -0.145; TCGA THCA -0.252; TCGA STAD -0.146; TCGA UCEC -0.207 |
hsa-miR-22-5p | HDAC2 | 9 cancers: BLCA; CESC; KIRC; KIRP; LGG; LIHC; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.072; TCGA CESC -0.075; TCGA KIRC -0.092; TCGA KIRP -0.121; TCGA LGG -0.136; TCGA LIHC -0.064; TCGA PRAD -0.203; TCGA THCA -0.077; TCGA UCEC -0.13 |
hsa-miR-22-5p | ZNF470 | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.178; TCGA BRCA -0.061; TCGA COAD -0.275; TCGA HNSC -0.39; TCGA KIRC -0.293; TCGA KIRP -0.149; TCGA LUAD -0.105; TCGA LUSC -0.174; TCGA PRAD -0.066; TCGA SARC -0.169; TCGA THCA -0.177; TCGA STAD -0.457; TCGA UCEC -0.077 |
hsa-miR-22-5p | KCTD7 | 10 cancers: BLCA; CESC; ESCA; KIRP; LIHC; LUSC; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.123; TCGA CESC -0.14; TCGA ESCA -0.183; TCGA KIRP -0.072; TCGA LIHC -0.103; TCGA LUSC -0.157; TCGA SARC -0.215; TCGA THCA -0.114; TCGA STAD -0.344; TCGA UCEC -0.192 |
hsa-miR-22-5p | ZNF704 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.485; TCGA BRCA -0.205; TCGA CESC -0.513; TCGA COAD -0.413; TCGA ESCA -0.36; TCGA HNSC -0.297; TCGA KIRC -0.481; TCGA KIRP -0.21; TCGA LGG -0.27; TCGA LUAD -0.396; TCGA LUSC -0.583; TCGA PAAD -0.444; TCGA PRAD -0.417; TCGA SARC -0.392; TCGA THCA -0.277; TCGA STAD -0.416; TCGA UCEC -0.305 |
hsa-miR-22-5p | BTRC | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.102; TCGA BRCA -0.17; TCGA COAD -0.058; TCGA KIRC -0.055; TCGA KIRP -0.071; TCGA LIHC -0.082; TCGA LUAD -0.055; TCGA PAAD -0.106; TCGA PRAD -0.098; TCGA STAD -0.137 |
hsa-miR-22-5p | SOS1 | 14 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.1; TCGA CESC -0.063; TCGA COAD -0.095; TCGA HNSC -0.159; TCGA KIRC -0.126; TCGA KIRP -0.118; TCGA LGG -0.124; TCGA LUAD -0.089; TCGA LUSC -0.122; TCGA PAAD -0.138; TCGA PRAD -0.155; TCGA SARC -0.153; TCGA STAD -0.144; TCGA UCEC -0.105 |
hsa-miR-22-5p | ZFR | 15 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.13; TCGA COAD -0.181; TCGA ESCA -0.081; TCGA HNSC -0.142; TCGA KIRC -0.112; TCGA KIRP -0.18; TCGA LIHC -0.077; TCGA LUAD -0.136; TCGA LUSC -0.117; TCGA PAAD -0.166; TCGA PRAD -0.17; TCGA SARC -0.072; TCGA THCA -0.163; TCGA STAD -0.136; TCGA UCEC -0.107 |
hsa-miR-22-5p | PDPK1 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.181; TCGA BRCA -0.103; TCGA COAD -0.11; TCGA ESCA -0.125; TCGA HNSC -0.195; TCGA KIRC -0.109; TCGA KIRP -0.073; TCGA LIHC -0.115; TCGA LUAD -0.124; TCGA LUSC -0.166; TCGA PAAD -0.161; TCGA PRAD -0.227; TCGA SARC -0.19; TCGA THCA -0.158 |
hsa-miR-22-5p | TP53BP2 | 12 cancers: BLCA; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.121; TCGA ESCA -0.098; TCGA HNSC -0.134; TCGA KIRP -0.124; TCGA LIHC -0.13; TCGA LUAD -0.074; TCGA LUSC -0.124; TCGA PRAD -0.107; TCGA SARC -0.058; TCGA THCA -0.319; TCGA STAD -0.078; TCGA UCEC -0.128 |
hsa-miR-22-5p | CGGBP1 | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.111; TCGA CESC -0.064; TCGA COAD -0.096; TCGA ESCA -0.106; TCGA HNSC -0.135; TCGA KIRC -0.076; TCGA KIRP -0.073; TCGA LGG -0.087; TCGA LUAD -0.108; TCGA LUSC -0.075; TCGA PRAD -0.126; TCGA SARC -0.097; TCGA THCA -0.056; TCGA STAD -0.147; TCGA UCEC -0.138 |
hsa-miR-22-5p | MBNL3 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.457; TCGA COAD -0.323; TCGA ESCA -0.312; TCGA HNSC -0.668; TCGA KIRC -0.236; TCGA KIRP -0.205; TCGA LIHC -0.297; TCGA LUAD -0.372; TCGA LUSC -0.394; TCGA PAAD -0.416; TCGA PRAD -0.484; TCGA THCA -0.362 |
hsa-miR-22-5p | C16orf52 | 10 cancers: BLCA; CESC; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.128; TCGA CESC -0.06; TCGA COAD -0.064; TCGA KIRC -0.085; TCGA KIRP -0.069; TCGA LUAD -0.111; TCGA LUSC -0.092; TCGA PAAD -0.091; TCGA STAD -0.147; TCGA UCEC -0.182 |
hsa-miR-22-5p | PTPN21 | 10 cancers: BLCA; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.113; TCGA ESCA -0.145; TCGA KIRC -0.103; TCGA KIRP -0.129; TCGA LUAD -0.171; TCGA LUSC -0.272; TCGA PAAD -0.104; TCGA THCA -0.095; TCGA STAD -0.229; TCGA UCEC -0.17 |
hsa-miR-22-5p | RBM27 | 13 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.123; TCGA COAD -0.1; TCGA HNSC -0.16; TCGA KIRC -0.104; TCGA KIRP -0.2; TCGA LGG -0.127; TCGA LUAD -0.173; TCGA LUSC -0.175; TCGA PAAD -0.172; TCGA PRAD -0.205; TCGA SARC -0.105; TCGA THCA -0.112; TCGA UCEC -0.123 |
hsa-miR-22-5p | EEF1A1 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.183; TCGA BRCA -0.087; TCGA CESC -0.095; TCGA ESCA -0.114; TCGA HNSC -0.086; TCGA KIRC -0.122; TCGA LGG -0.294; TCGA LIHC -0.182; TCGA LUAD -0.201; TCGA PAAD -0.134; TCGA PRAD -0.161; TCGA THCA -0.221 |
hsa-miR-22-5p | FOXP1 | 9 cancers: BLCA; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.183; TCGA ESCA -0.322; TCGA HNSC -0.075; TCGA LIHC -0.188; TCGA LUAD -0.06; TCGA LUSC -0.174; TCGA PRAD -0.11; TCGA SARC -0.1; TCGA STAD -0.227 |
hsa-miR-22-5p | JMY | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.292; TCGA BRCA -0.08; TCGA CESC -0.183; TCGA COAD -0.089; TCGA HNSC -0.163; TCGA KIRP -0.173; TCGA LGG -0.146; TCGA LUAD -0.144; TCGA LUSC -0.118; TCGA PAAD -0.17; TCGA PRAD -0.151; TCGA SARC -0.286; TCGA THCA -0.124; TCGA STAD -0.337; TCGA UCEC -0.149 |
hsa-miR-22-5p | EPHA3 | 9 cancers: BLCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.259; TCGA COAD -0.385; TCGA HNSC -0.209; TCGA KIRC -0.291; TCGA LUAD -0.347; TCGA LUSC -0.427; TCGA PAAD -0.528; TCGA PRAD -0.16; TCGA STAD -0.605 |
hsa-miR-22-5p | ATF6 | 14 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.059; TCGA COAD -0.142; TCGA HNSC -0.13; TCGA KIRC -0.16; TCGA KIRP -0.201; TCGA LIHC -0.157; TCGA LUAD -0.14; TCGA LUSC -0.146; TCGA PAAD -0.171; TCGA PRAD -0.264; TCGA SARC -0.11; TCGA THCA -0.203; TCGA STAD -0.063; TCGA UCEC -0.12 |
hsa-miR-22-5p | ATP7B | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD | MirTarget | TCGA BRCA -0.204; TCGA CESC -0.432; TCGA ESCA -0.415; TCGA HNSC -0.212; TCGA KIRC -0.214; TCGA KIRP -0.134; TCGA LGG -0.147; TCGA LIHC -0.179; TCGA LUAD -0.181; TCGA LUSC -0.293; TCGA PRAD -0.363 |
hsa-miR-22-5p | ATRN | 11 cancers: BRCA; CESC; COAD; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BRCA -0.066; TCGA CESC -0.117; TCGA COAD -0.174; TCGA KIRC -0.105; TCGA KIRP -0.118; TCGA LIHC -0.183; TCGA LUAD -0.087; TCGA PAAD -0.174; TCGA PRAD -0.207; TCGA THCA -0.085; TCGA UCEC -0.08 |
hsa-miR-22-5p | SUPT16H | 11 cancers: BRCA; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.06; TCGA KIRC -0.111; TCGA KIRP -0.122; TCGA LGG -0.195; TCGA LIHC -0.125; TCGA LUAD -0.061; TCGA PAAD -0.067; TCGA PRAD -0.123; TCGA SARC -0.088; TCGA THCA -0.166; TCGA UCEC -0.148 |
hsa-miR-22-5p | ASB1 | 11 cancers: BRCA; ESCA; KIRC; LGG; LIHC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.098; TCGA ESCA -0.111; TCGA KIRC -0.082; TCGA LGG -0.127; TCGA LIHC -0.11; TCGA PAAD -0.099; TCGA PRAD -0.054; TCGA SARC -0.104; TCGA THCA -0.266; TCGA STAD -0.17; TCGA UCEC -0.157 |
hsa-miR-22-5p | RGP1 | 13 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BRCA -0.171; TCGA COAD -0.103; TCGA ESCA -0.196; TCGA HNSC -0.232; TCGA KIRC -0.384; TCGA KIRP -0.218; TCGA LUAD -0.19; TCGA LUSC -0.372; TCGA PAAD -0.222; TCGA PRAD -0.327; TCGA SARC -0.292; TCGA THCA -0.377; TCGA UCEC -0.093 |
hsa-miR-22-5p | DDX31 | 10 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; PRAD; THCA | mirMAP | TCGA BRCA -0.066; TCGA COAD -0.087; TCGA ESCA -0.098; TCGA KIRC -0.073; TCGA KIRP -0.213; TCGA LGG -0.165; TCGA LIHC -0.104; TCGA LUAD -0.053; TCGA PRAD -0.104; TCGA THCA -0.1 |
hsa-miR-22-5p | PRRG4 | 9 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BRCA -0.123; TCGA COAD -0.143; TCGA HNSC -0.124; TCGA KIRC -0.328; TCGA KIRP -0.188; TCGA LUAD -0.169; TCGA PRAD -0.114; TCGA SARC -0.472; TCGA THCA -0.159 |
hsa-miR-22-5p | SNX30 | 9 cancers: BRCA; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP | TCGA BRCA -0.068; TCGA COAD -0.142; TCGA HNSC -0.14; TCGA LIHC -0.111; TCGA LUAD -0.372; TCGA LUSC -0.336; TCGA PAAD -0.134; TCGA PRAD -0.192; TCGA THCA -0.338 |
hsa-miR-22-5p | CSNK1G1 | 9 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD | mirMAP | TCGA BRCA -0.056; TCGA COAD -0.086; TCGA HNSC -0.094; TCGA KIRC -0.116; TCGA KIRP -0.173; TCGA LIHC -0.103; TCGA LUAD -0.114; TCGA PAAD -0.097; TCGA PRAD -0.221 |
hsa-miR-22-5p | PLCXD3 | 10 cancers: BRCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.462; TCGA CESC -0.503; TCGA ESCA -0.642; TCGA LUAD -0.314; TCGA LUSC -0.386; TCGA PAAD -0.693; TCGA PRAD -0.178; TCGA SARC -0.593; TCGA STAD -0.858; TCGA UCEC -0.577 |
hsa-miR-22-5p | PTPRT | 10 cancers: BRCA; CESC; COAD; HNSC; LGG; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.62; TCGA CESC -0.592; TCGA COAD -0.4; TCGA HNSC -0.75; TCGA LGG -0.464; TCGA LUSC -0.598; TCGA PAAD -0.444; TCGA SARC -0.314; TCGA STAD -0.403; TCGA UCEC -0.508 |
hsa-miR-22-5p | IGF1R | 9 cancers: BRCA; KIRC; KIRP; LGG; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.296; TCGA KIRC -0.218; TCGA KIRP -0.257; TCGA LGG -0.234; TCGA PRAD -0.258; TCGA SARC -0.287; TCGA THCA -0.41; TCGA STAD -0.211; TCGA UCEC -0.205 |
hsa-miR-22-5p | CTDSPL | 12 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BRCA -0.097; TCGA ESCA -0.206; TCGA HNSC -0.081; TCGA KIRC -0.103; TCGA KIRP -0.091; TCGA LIHC -0.091; TCGA LUAD -0.227; TCGA LUSC -0.106; TCGA PRAD -0.051; TCGA SARC -0.182; TCGA THCA -0.196; TCGA STAD -0.107 |
hsa-miR-22-5p | ETV1 | 10 cancers: CESC; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA CESC -0.319; TCGA HNSC -0.345; TCGA KIRP -0.663; TCGA LGG -0.547; TCGA LUAD -0.326; TCGA LUSC -0.353; TCGA PAAD -0.275; TCGA PRAD -0.207; TCGA THCA -0.278; TCGA STAD -0.289 |
hsa-miR-22-5p | SYT11 | 11 cancers: CESC; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.176; TCGA COAD -0.178; TCGA HNSC -0.151; TCGA KIRC -0.188; TCGA LUAD -0.112; TCGA LUSC -0.454; TCGA PAAD -0.334; TCGA SARC -0.282; TCGA THCA -0.238; TCGA STAD -0.357; TCGA UCEC -0.307 |
hsa-miR-22-5p | GPBP1 | 10 cancers: CESC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA; UCEC | MirTarget; miRNATAP | TCGA CESC -0.059; TCGA KIRC -0.107; TCGA KIRP -0.136; TCGA LGG -0.078; TCGA LIHC -0.102; TCGA LUAD -0.086; TCGA LUSC -0.103; TCGA PRAD -0.061; TCGA THCA -0.064; TCGA UCEC -0.101 |
hsa-miR-22-5p | ZNF286A | 10 cancers: CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA CESC -0.08; TCGA HNSC -0.104; TCGA KIRC -0.185; TCGA KIRP -0.171; TCGA LGG -0.218; TCGA LIHC -0.084; TCGA LUSC -0.096; TCGA PRAD -0.101; TCGA STAD -0.106; TCGA UCEC -0.071 |
hsa-miR-22-5p | RBBP9 | 9 cancers: CESC; COAD; HNSC; LGG; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA CESC -0.187; TCGA COAD -0.15; TCGA HNSC -0.136; TCGA LGG -0.098; TCGA LUAD -0.106; TCGA LUSC -0.111; TCGA PRAD -0.144; TCGA STAD -0.154; TCGA UCEC -0.086 |
hsa-miR-22-5p | NEDD4 | 9 cancers: COAD; KIRC; LGG; LIHC; LUAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA COAD -0.21; TCGA KIRC -0.152; TCGA LGG -0.144; TCGA LIHC -0.191; TCGA LUAD -0.117; TCGA SARC -0.111; TCGA THCA -0.086; TCGA STAD -0.189; TCGA UCEC -0.14 |
hsa-miR-22-5p | RBM41 | 9 cancers: COAD; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA COAD -0.109; TCGA KIRP -0.218; TCGA LGG -0.052; TCGA LIHC -0.069; TCGA LUAD -0.069; TCGA PRAD -0.197; TCGA SARC -0.153; TCGA THCA -0.117; TCGA STAD -0.151 |
hsa-miR-22-5p | MOSPD2 | 10 cancers: COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA COAD -0.187; TCGA HNSC -0.151; TCGA KIRC -0.148; TCGA KIRP -0.146; TCGA LUAD -0.183; TCGA LUSC -0.242; TCGA PRAD -0.258; TCGA THCA -0.172; TCGA STAD -0.12; TCGA UCEC -0.097 |
hsa-miR-22-5p | ZBTB33 | 12 cancers: COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA COAD -0.16; TCGA HNSC -0.184; TCGA KIRC -0.095; TCGA KIRP -0.115; TCGA LGG -0.104; TCGA LIHC -0.097; TCGA LUAD -0.097; TCGA LUSC -0.098; TCGA PAAD -0.147; TCGA PRAD -0.199; TCGA THCA -0.286; TCGA UCEC -0.098 |
hsa-miR-22-5p | NOL8 | 9 cancers: COAD; KIRP; LGG; LIHC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA COAD -0.079; TCGA KIRP -0.062; TCGA LGG -0.109; TCGA LIHC -0.067; TCGA PAAD -0.07; TCGA PRAD -0.102; TCGA THCA -0.068; TCGA STAD -0.07; TCGA UCEC -0.102 |
hsa-miR-22-5p | MAP3K2 | 11 cancers: COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA COAD -0.186; TCGA HNSC -0.15; TCGA KIRC -0.139; TCGA KIRP -0.265; TCGA LUAD -0.156; TCGA LUSC -0.085; TCGA PAAD -0.171; TCGA PRAD -0.326; TCGA SARC -0.128; TCGA THCA -0.297; TCGA STAD -0.126 |
hsa-miR-22-5p | ELK3 | 10 cancers: COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA COAD -0.172; TCGA HNSC -0.138; TCGA KIRC -0.369; TCGA KIRP -0.296; TCGA LUAD -0.111; TCGA LUSC -0.167; TCGA PRAD -0.241; TCGA THCA -0.327; TCGA STAD -0.132; TCGA UCEC -0.154 |
hsa-miR-22-5p | IARS | 9 cancers: COAD; HNSC; KIRP; LIHC; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA COAD -0.12; TCGA HNSC -0.088; TCGA KIRP -0.113; TCGA LIHC -0.083; TCGA LUSC -0.083; TCGA PAAD -0.115; TCGA PRAD -0.159; TCGA THCA -0.164; TCGA UCEC -0.07 |
hsa-miR-22-5p | SAMD8 | 10 cancers: COAD; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; THCA; STAD | MirTarget | TCGA COAD -0.129; TCGA HNSC -0.158; TCGA KIRC -0.206; TCGA KIRP -0.117; TCGA LGG -0.144; TCGA LUAD -0.187; TCGA PAAD -0.165; TCGA PRAD -0.238; TCGA THCA -0.23; TCGA STAD -0.243 |
hsa-miR-22-5p | ACLY | 9 cancers: COAD; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; THCA | MirTarget | TCGA COAD -0.07; TCGA KIRC -0.218; TCGA KIRP -0.203; TCGA LGG -0.08; TCGA LIHC -0.137; TCGA LUSC -0.078; TCGA PAAD -0.155; TCGA PRAD -0.151; TCGA THCA -0.072 |
hsa-miR-22-5p | QKI | 9 cancers: COAD; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA COAD -0.174; TCGA KIRC -0.122; TCGA KIRP -0.106; TCGA LGG -0.124; TCGA LUAD -0.193; TCGA LUSC -0.237; TCGA PRAD -0.111; TCGA STAD -0.238; TCGA UCEC -0.181 |
hsa-miR-22-5p | NCOA3 | 10 cancers: COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PRAD; THCA; STAD | mirMAP | TCGA COAD -0.121; TCGA HNSC -0.074; TCGA KIRC -0.188; TCGA KIRP -0.116; TCGA LGG -0.102; TCGA LIHC -0.138; TCGA LUAD -0.059; TCGA PRAD -0.21; TCGA THCA -0.055; TCGA STAD -0.091 |
hsa-miR-22-5p | POGK | 13 cancers: COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA COAD -0.102; TCGA HNSC -0.116; TCGA KIRC -0.055; TCGA KIRP -0.201; TCGA LGG -0.121; TCGA LIHC -0.169; TCGA LUAD -0.069; TCGA LUSC -0.141; TCGA PAAD -0.132; TCGA PRAD -0.132; TCGA SARC -0.13; TCGA THCA -0.138; TCGA UCEC -0.11 |
hsa-miR-22-5p | XPO1 | 9 cancers: COAD; KIRC; KIRP; LGG; LIHC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA COAD -0.091; TCGA KIRC -0.057; TCGA KIRP -0.112; TCGA LGG -0.083; TCGA LIHC -0.099; TCGA PRAD -0.149; TCGA SARC -0.058; TCGA STAD -0.076; TCGA UCEC -0.117 |
hsa-miR-22-5p | HLCS | 10 cancers: COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA COAD -0.069; TCGA ESCA -0.114; TCGA HNSC -0.184; TCGA KIRP -0.104; TCGA LUAD -0.062; TCGA LUSC -0.075; TCGA PAAD -0.105; TCGA PRAD -0.081; TCGA SARC -0.15; TCGA THCA -0.058 |
hsa-miR-22-5p | FER | 11 cancers: HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA HNSC -0.143; TCGA KIRC -0.278; TCGA KIRP -0.247; TCGA LIHC -0.096; TCGA LUAD -0.241; TCGA LUSC -0.262; TCGA PAAD -0.171; TCGA PRAD -0.288; TCGA SARC -0.09; TCGA THCA -0.289; TCGA STAD -0.228 |
hsa-miR-22-5p | PURB | 9 cancers: KIRC; KIRP; LGG; LIHC; PRAD; SARC; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA KIRC -0.156; TCGA KIRP -0.174; TCGA LGG -0.095; TCGA LIHC -0.057; TCGA PRAD -0.132; TCGA SARC -0.12; TCGA THCA -0.114; TCGA STAD -0.177; TCGA UCEC -0.141 |
hsa-miR-22-5p | SGMS1 | 9 cancers: KIRC; KIRP; LGG; LUAD; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA KIRC -0.155; TCGA KIRP -0.146; TCGA LGG -0.152; TCGA LUAD -0.262; TCGA PAAD -0.165; TCGA PRAD -0.248; TCGA THCA -0.33; TCGA STAD -0.068; TCGA UCEC -0.092 |
Enriched cancer pathways of putative targets